Laurel Rauschenbach
Overview
Explore the profile of Laurel Rauschenbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Said M, Gumus M, Riess C, Dinger T, Rauschenbach L, Rodemerk J, et al.
Acta Neurochir (Wien)
. 2024 Jun;
166(1):245.
PMID: 38829543
Background: Thyroid hormones were reported to exert neuroprotective effects after ischemic stroke by reducing the burden of brain injury and promoting post-ischemic brain remodeling. Objective: We aimed to analyze the...
12.
Rauschenbach L, Kolbe P, Engel A, Ahmadipour Y, Oppong M, Santos A, et al.
J Neurooncol
. 2024 May;
169(1):165-173.
PMID: 38801490
Purpose: Intracerebral metastases present a substantial risk of tumor-associated intracerebral hemorrhage (ICH). This study aimed to investigate the risk of hemorrhagic events in brain metastases (BM) from various primary tumor...
13.
Rauschenbach L, Bartsch P, Santos A, Michel A, Gull H, Ketelauri P, et al.
J Neurosurg Sci
. 2024 Mar;
69(1):102-110.
PMID: 38483435
Background: The aim of this study was to assess health-related quality of life (HRQOL) before and after treatment for intracerebral low-grade glioma. Methods: Patients with low-grade glioma who underwent surgical...
14.
Lenkeit A, Oppong M, Dinger T, Gumus M, Rauschenbach L, Chihi M, et al.
Acta Neurochir (Wien)
. 2024 Feb;
166(1):93.
PMID: 38376665
Background: Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating diagnosis. A poor outcome is known to be highly dependent on the initial neurological status. Our goal was to identify other parameters...
15.
Ullrich V, Ertmer S, Baginska A, Dorsch M, Gull H, Cima I, et al.
iScience
. 2024 Jan;
27(1):108596.
PMID: 38174322
Adaptive plasticity to the standard chemotherapeutic temozolomide (TMZ) leads to glioblastoma progression. Here, we examine early stages of this process in patient-derived cellular models, exposing the human lysine-specific demethylase 5B...
16.
Santos A, Rauschenbach L, Gull H, Olbrich A, Dinger T, Oppong M, et al.
Sci Rep
. 2023 Sep;
13(1):15490.
PMID: 37726391
Knowledge of the bleeding risk and the long-term outcome of conservatively treated patients with cavernous malformations (CM) is poor. In this work, we studied the occurrence of CM-associated hemorrhage over...
17.
Santos A, Rauschenbach L, Riess C, Georgiades I, Ficilar B, Gallardo E, et al.
Seizure
. 2023 Jul;
111:23-29.
PMID: 37494759
Objective: This study aimed to investigate and compare the outcome of conservatively or surgically treated children with cerebral cavernous malformation (CCM) and new-onset CCM-related epilepsy (CRE) during a 5-year period....
18.
Ratliff M, Karimian-Jazi K, Hoffmann D, Rauschenbach L, Simon M, Hai L, et al.
Neuro Oncol
. 2023 Jun;
25(12):2150-2162.
PMID: 37335907
Background: Glioblastomas are characterized by aggressive and infiltrative growth, and by striking heterogeneity. The aim of this study was to investigate whether tumor cell proliferation and invasion are interrelated, or...
19.
Johny J, van Halteren C, Cakir F, Zwiehoff S, Behrends C, Baumer C, et al.
Chemistry
. 2023 Jun;
29(50):e202301260.
PMID: 37334753
Gold nanoparticles (AuNPs) are currently the most studied radiosensitizers in proton therapy (PT) applicable for the treatment of solid tumors, where they amplify production of reactive oxygen species (ROS). However,...
20.
Li J, Ellis D, Kodym O, Rauschenbach L, Riess C, Sure U, et al.
Med Image Anal
. 2023 Jun;
88:102865.
PMID: 37331241
Cranial implants are commonly used for surgical repair of craniectomy-induced skull defects. These implants are usually generated offline and may require days to weeks to be available. An automated implant...